Erythropoietin and cerebral vascular protection: Role of nitric oxide

A. V R Santhanam, Zvonimir S Katusic

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Cerebral vasospasm after subarachnoid hemorrhage (SAH) is a major clinical problem causing cerebral ischemia and infarction. The pathogenesis of vasospasm is related to a number of pathological processes including endothelial damage and alterations in vasomotor function leading to narrowing of arterial diameter and a subsequent decrease in cerebral blood flow. Discovery of the tissue protective effects of erythropoietin (EPO) stimulated the search for therapeutic application of EPO for the prevention and treatment of cerebrovascular disease. Recent studies have identified the role of EPO in vascular protection mediated by the preservation of endothelial cell integrity and stimulation of angiogenesis. In this review, we discuss the EPO-induced activation of endothelial nitric oxide (NO) synthase and its contribution to the prevention of cerebral vasospasm.

Original languageEnglish (US)
Pages (from-to)1389-1394
Number of pages6
JournalActa Pharmacologica Sinica
Volume27
Issue number11
DOIs
StatePublished - Nov 2006

Fingerprint

Erythropoietin
Blood Vessels
Nitric Oxide
Intracranial Vasospasm
Cerebrovascular Circulation
Cerebrovascular Disorders
Nitric Oxide Synthase Type III
Endothelial cells
Cerebral Infarction
Pathologic Processes
Subarachnoid Hemorrhage
Brain Ischemia
Blood
Endothelial Cells
Chemical activation
Tissue
Therapeutics

Keywords

  • Cerebral vasospasm
  • Endothelium
  • Nitric oxide synthase
  • Tissue protection

ASJC Scopus subject areas

  • Chemistry(all)
  • Pharmacology

Cite this

Erythropoietin and cerebral vascular protection : Role of nitric oxide. / Santhanam, A. V R; Katusic, Zvonimir S.

In: Acta Pharmacologica Sinica, Vol. 27, No. 11, 11.2006, p. 1389-1394.

Research output: Contribution to journalArticle

@article{04a94bf0051042dd848f9dbbed475dc7,
title = "Erythropoietin and cerebral vascular protection: Role of nitric oxide",
abstract = "Cerebral vasospasm after subarachnoid hemorrhage (SAH) is a major clinical problem causing cerebral ischemia and infarction. The pathogenesis of vasospasm is related to a number of pathological processes including endothelial damage and alterations in vasomotor function leading to narrowing of arterial diameter and a subsequent decrease in cerebral blood flow. Discovery of the tissue protective effects of erythropoietin (EPO) stimulated the search for therapeutic application of EPO for the prevention and treatment of cerebrovascular disease. Recent studies have identified the role of EPO in vascular protection mediated by the preservation of endothelial cell integrity and stimulation of angiogenesis. In this review, we discuss the EPO-induced activation of endothelial nitric oxide (NO) synthase and its contribution to the prevention of cerebral vasospasm.",
keywords = "Cerebral vasospasm, Endothelium, Nitric oxide synthase, Tissue protection",
author = "Santhanam, {A. V R} and Katusic, {Zvonimir S}",
year = "2006",
month = "11",
doi = "10.1111/j.1745-7254.2006.00441.x",
language = "English (US)",
volume = "27",
pages = "1389--1394",
journal = "Zhongguo yao li xue bao = Acta pharmacologica Sinica",
issn = "1671-4083",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - Erythropoietin and cerebral vascular protection

T2 - Role of nitric oxide

AU - Santhanam, A. V R

AU - Katusic, Zvonimir S

PY - 2006/11

Y1 - 2006/11

N2 - Cerebral vasospasm after subarachnoid hemorrhage (SAH) is a major clinical problem causing cerebral ischemia and infarction. The pathogenesis of vasospasm is related to a number of pathological processes including endothelial damage and alterations in vasomotor function leading to narrowing of arterial diameter and a subsequent decrease in cerebral blood flow. Discovery of the tissue protective effects of erythropoietin (EPO) stimulated the search for therapeutic application of EPO for the prevention and treatment of cerebrovascular disease. Recent studies have identified the role of EPO in vascular protection mediated by the preservation of endothelial cell integrity and stimulation of angiogenesis. In this review, we discuss the EPO-induced activation of endothelial nitric oxide (NO) synthase and its contribution to the prevention of cerebral vasospasm.

AB - Cerebral vasospasm after subarachnoid hemorrhage (SAH) is a major clinical problem causing cerebral ischemia and infarction. The pathogenesis of vasospasm is related to a number of pathological processes including endothelial damage and alterations in vasomotor function leading to narrowing of arterial diameter and a subsequent decrease in cerebral blood flow. Discovery of the tissue protective effects of erythropoietin (EPO) stimulated the search for therapeutic application of EPO for the prevention and treatment of cerebrovascular disease. Recent studies have identified the role of EPO in vascular protection mediated by the preservation of endothelial cell integrity and stimulation of angiogenesis. In this review, we discuss the EPO-induced activation of endothelial nitric oxide (NO) synthase and its contribution to the prevention of cerebral vasospasm.

KW - Cerebral vasospasm

KW - Endothelium

KW - Nitric oxide synthase

KW - Tissue protection

UR - http://www.scopus.com/inward/record.url?scp=33750282229&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750282229&partnerID=8YFLogxK

U2 - 10.1111/j.1745-7254.2006.00441.x

DO - 10.1111/j.1745-7254.2006.00441.x

M3 - Article

C2 - 17049112

AN - SCOPUS:33750282229

VL - 27

SP - 1389

EP - 1394

JO - Zhongguo yao li xue bao = Acta pharmacologica Sinica

JF - Zhongguo yao li xue bao = Acta pharmacologica Sinica

SN - 1671-4083

IS - 11

ER -